Beijing: China has reportedly approved patent for CanSino Biologics Inc’s COVID-19 vaccine — Ad5-nCOV. It is the first patent granted by China for a COVID-19 vaccine.
Saudi Arabia will be carrying out the Phase-III clinical trials for the CanSino vaccine this month.
CanSino is exploring testing the vaccine in Russia, Brazil and Chile as well. CanSino’s Hong Kong shares rose by around 14 per cent on Monday.
Also Read: First Batch Of Russian COVID-19 Vaccine To Roll Out This Month
Bhubaneswar: Much to the delight of home fans at the Kalinga Stadium here on Saturday, Odisha’s U-15 girls team clinched...
Rayagada: A forest official lost his life in a car crash in Odisha's Rayagada district on late Friday evening. The...
Bhubaneswar: Rail services faced partial disruption on Sunday evening after at least three wagons of a coal-laden goods train derailed...
Bhubaneswar: Odisha women retained their beach soccer title in the Khelo India Beach Games (KIBG) 2026 on Friday. The defending...
Copyright © 2025 Frontier Media
